nodes	percent_of_prediction	percent_of_DWPC	metapath
Carfilzomib—ABCB1—Lisinopril—dilated cardiomyopathy	0.184	0.532	CbGbCtD
Carfilzomib—ABCB1—Spironolactone—dilated cardiomyopathy	0.162	0.468	CbGbCtD
Carfilzomib—PSMB10—heart—dilated cardiomyopathy	0.0211	0.109	CbGeAlD
Carfilzomib—PSMB5—cardiac ventricle—dilated cardiomyopathy	0.0183	0.0944	CbGeAlD
Carfilzomib—PSMB5—myocardium—dilated cardiomyopathy	0.0172	0.0888	CbGeAlD
Carfilzomib—PSMB1—cardiac ventricle—dilated cardiomyopathy	0.016	0.0825	CbGeAlD
Carfilzomib—PSMB2—cardiac ventricle—dilated cardiomyopathy	0.0156	0.0805	CbGeAlD
Carfilzomib—PSMB1—myocardium—dilated cardiomyopathy	0.015	0.0776	CbGeAlD
Carfilzomib—PSMB2—myocardium—dilated cardiomyopathy	0.0147	0.0757	CbGeAlD
Carfilzomib—PSMB8—heart—dilated cardiomyopathy	0.0136	0.0702	CbGeAlD
Carfilzomib—PSMB5—heart—dilated cardiomyopathy	0.012	0.062	CbGeAlD
Carfilzomib—PSMB1—heart—dilated cardiomyopathy	0.0105	0.0542	CbGeAlD
Carfilzomib—PSMB5—cardiac atrium—dilated cardiomyopathy	0.0103	0.053	CbGeAlD
Carfilzomib—PSMB2—heart—dilated cardiomyopathy	0.0102	0.0528	CbGeAlD
Carfilzomib—PSMB8—Testosterone Propionate—Spironolactone—dilated cardiomyopathy	0.0101	1	CbGdCrCtD
Carfilzomib—PSMB1—cardiac atrium—dilated cardiomyopathy	0.00897	0.0463	CbGeAlD
Carfilzomib—PSMB2—cardiac atrium—dilated cardiomyopathy	0.00875	0.0452	CbGeAlD
Carfilzomib—Hypomagnesaemia—Furosemide—dilated cardiomyopathy	0.00665	0.0538	CcSEcCtD
Carfilzomib—Renal failure acute—Spironolactone—dilated cardiomyopathy	0.00611	0.0494	CcSEcCtD
Carfilzomib—Renal failure—Spironolactone—dilated cardiomyopathy	0.00427	0.0346	CcSEcCtD
Carfilzomib—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00326	0.0264	CcSEcCtD
Carfilzomib—Hyponatraemia—Furosemide—dilated cardiomyopathy	0.00308	0.0249	CcSEcCtD
Carfilzomib—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00304	0.0246	CcSEcCtD
Carfilzomib—Blood creatinine increased—Furosemide—dilated cardiomyopathy	0.00287	0.0232	CcSEcCtD
Carfilzomib—Hypokalaemia—Furosemide—dilated cardiomyopathy	0.00279	0.0226	CcSEcCtD
Carfilzomib—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00271	0.0219	CcSEcCtD
Carfilzomib—Hepatic failure—Lisinopril—dilated cardiomyopathy	0.00256	0.0207	CcSEcCtD
Carfilzomib—Renal failure acute—Lisinopril—dilated cardiomyopathy	0.00249	0.0202	CcSEcCtD
Carfilzomib—Hyperglycaemia—Furosemide—dilated cardiomyopathy	0.00239	0.0193	CcSEcCtD
Carfilzomib—Renal failure—Furosemide—dilated cardiomyopathy	0.00232	0.0188	CcSEcCtD
Carfilzomib—Hyponatraemia—Lisinopril—dilated cardiomyopathy	0.00231	0.0187	CcSEcCtD
Carfilzomib—Pain in extremity—Lisinopril—dilated cardiomyopathy	0.0023	0.0186	CcSEcCtD
Carfilzomib—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00219	0.0177	CcSEcCtD
Carfilzomib—Cardiac arrest—Lisinopril—dilated cardiomyopathy	0.00219	0.0177	CcSEcCtD
Carfilzomib—Blood creatinine increased—Lisinopril—dilated cardiomyopathy	0.00216	0.0174	CcSEcCtD
Carfilzomib—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.0019	0.0153	CcSEcCtD
Carfilzomib—Neutropenia—Lisinopril—dilated cardiomyopathy	0.00186	0.015	CcSEcCtD
Carfilzomib—Upper respiratory tract infection—Lisinopril—dilated cardiomyopathy	0.00185	0.015	CcSEcCtD
Carfilzomib—Dizziness—Spironolactone—dilated cardiomyopathy	0.00183	0.0148	CcSEcCtD
Carfilzomib—Hyperglycaemia—Lisinopril—dilated cardiomyopathy	0.00179	0.0145	CcSEcCtD
Carfilzomib—Pneumonia—Lisinopril—dilated cardiomyopathy	0.00178	0.0144	CcSEcCtD
Carfilzomib—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00178	0.0144	CcSEcCtD
Carfilzomib—Vomiting—Spironolactone—dilated cardiomyopathy	0.00176	0.0143	CcSEcCtD
Carfilzomib—Acute coronary syndrome—Lisinopril—dilated cardiomyopathy	0.00175	0.0141	CcSEcCtD
Carfilzomib—Renal failure—Lisinopril—dilated cardiomyopathy	0.00174	0.0141	CcSEcCtD
Carfilzomib—Neuropathy peripheral—Lisinopril—dilated cardiomyopathy	0.00174	0.0141	CcSEcCtD
Carfilzomib—Headache—Spironolactone—dilated cardiomyopathy	0.00174	0.014	CcSEcCtD
Carfilzomib—Anaemia—Furosemide—dilated cardiomyopathy	0.00171	0.0138	CcSEcCtD
Carfilzomib—Leukopenia—Furosemide—dilated cardiomyopathy	0.00165	0.0134	CcSEcCtD
Carfilzomib—Nausea—Spironolactone—dilated cardiomyopathy	0.00165	0.0133	CcSEcCtD
Carfilzomib—Oedema peripheral—Lisinopril—dilated cardiomyopathy	0.00157	0.0127	CcSEcCtD
Carfilzomib—ABCB1—heart—dilated cardiomyopathy	0.00156	0.00807	CbGeAlD
Carfilzomib—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00148	0.0119	CcSEcCtD
Carfilzomib—Anorexia—Furosemide—dilated cardiomyopathy	0.00144	0.0116	CcSEcCtD
Carfilzomib—Chills—Lisinopril—dilated cardiomyopathy	0.00143	0.0116	CcSEcCtD
Carfilzomib—Back pain—Lisinopril—dilated cardiomyopathy	0.00134	0.0108	CcSEcCtD
Carfilzomib—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00133	0.0108	CcSEcCtD
Carfilzomib—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00131	0.0106	CcSEcCtD
Carfilzomib—Fatigue—Furosemide—dilated cardiomyopathy	0.0013	0.0105	CcSEcCtD
Carfilzomib—Pain—Furosemide—dilated cardiomyopathy	0.00129	0.0104	CcSEcCtD
Carfilzomib—Constipation—Furosemide—dilated cardiomyopathy	0.00129	0.0104	CcSEcCtD
Carfilzomib—Anaemia—Lisinopril—dilated cardiomyopathy	0.00128	0.0104	CcSEcCtD
Carfilzomib—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00124	0.01	CcSEcCtD
Carfilzomib—Cough—Lisinopril—dilated cardiomyopathy	0.00121	0.00978	CcSEcCtD
Carfilzomib—Body temperature increased—Furosemide—dilated cardiomyopathy	0.00119	0.00964	CcSEcCtD
Carfilzomib—Arthralgia—Lisinopril—dilated cardiomyopathy	0.00118	0.00955	CcSEcCtD
Carfilzomib—Infection—Lisinopril—dilated cardiomyopathy	0.00112	0.00909	CcSEcCtD
Carfilzomib—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00111	0.00896	CcSEcCtD
Carfilzomib—Asthenia—Furosemide—dilated cardiomyopathy	0.00108	0.00875	CcSEcCtD
Carfilzomib—Anorexia—Lisinopril—dilated cardiomyopathy	0.00108	0.00872	CcSEcCtD
Carfilzomib—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00103	0.00834	CcSEcCtD
Carfilzomib—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00103	0.00834	CcSEcCtD
Carfilzomib—Insomnia—Lisinopril—dilated cardiomyopathy	0.00102	0.00828	CcSEcCtD
Carfilzomib—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00101	0.00816	CcSEcCtD
Carfilzomib—Dizziness—Furosemide—dilated cardiomyopathy	0.000997	0.00807	CcSEcCtD
Carfilzomib—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.000983	0.00795	CcSEcCtD
Carfilzomib—Fatigue—Lisinopril—dilated cardiomyopathy	0.000975	0.00789	CcSEcCtD
Carfilzomib—Pain—Lisinopril—dilated cardiomyopathy	0.000967	0.00783	CcSEcCtD
Carfilzomib—Constipation—Lisinopril—dilated cardiomyopathy	0.000967	0.00783	CcSEcCtD
Carfilzomib—Vomiting—Furosemide—dilated cardiomyopathy	0.000958	0.00775	CcSEcCtD
Carfilzomib—Headache—Furosemide—dilated cardiomyopathy	0.000944	0.00764	CcSEcCtD
Carfilzomib—Nausea—Furosemide—dilated cardiomyopathy	0.000895	0.00724	CcSEcCtD
Carfilzomib—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.000894	0.00723	CcSEcCtD
Carfilzomib—Asthenia—Lisinopril—dilated cardiomyopathy	0.000811	0.00657	CcSEcCtD
Carfilzomib—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.000774	0.00626	CcSEcCtD
Carfilzomib—Dizziness—Lisinopril—dilated cardiomyopathy	0.000748	0.00605	CcSEcCtD
Carfilzomib—Vomiting—Lisinopril—dilated cardiomyopathy	0.000719	0.00582	CcSEcCtD
Carfilzomib—Headache—Lisinopril—dilated cardiomyopathy	0.000708	0.00573	CcSEcCtD
Carfilzomib—Nausea—Lisinopril—dilated cardiomyopathy	0.000672	0.00544	CcSEcCtD
Carfilzomib—PSMB1—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.00054	0.00165	CbGpPWpGaD
Carfilzomib—PSMB8—Class I MHC mediated antigen processing & presentation—CD36—dilated cardiomyopathy	0.000536	0.00164	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle, Mitotic—LMNA—dilated cardiomyopathy	0.000533	0.00163	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—TAZ—dilated cardiomyopathy	0.000527	0.00161	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—TAZ—dilated cardiomyopathy	0.000527	0.00161	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—TAZ—dilated cardiomyopathy	0.000527	0.00161	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—TAZ—dilated cardiomyopathy	0.00052	0.00159	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—AGTR1—dilated cardiomyopathy	0.000517	0.00158	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—NR3C2—dilated cardiomyopathy	0.0005	0.00153	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—NR3C2—dilated cardiomyopathy	0.0005	0.00153	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—NR3C2—dilated cardiomyopathy	0.0005	0.00153	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—NR3C2—dilated cardiomyopathy	0.000493	0.00151	CbGpPWpGaD
Carfilzomib—PSMB2—Cell Cycle—LMNA—dilated cardiomyopathy	0.000483	0.00148	CbGpPWpGaD
Carfilzomib—PSMB5—Cell Cycle—LMNA—dilated cardiomyopathy	0.000483	0.00148	CbGpPWpGaD
Carfilzomib—PSMB1—Cell Cycle—LMNA—dilated cardiomyopathy	0.000483	0.00148	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—SDHA—dilated cardiomyopathy	0.000477	0.00146	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—SDHA—dilated cardiomyopathy	0.000477	0.00146	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—SDHA—dilated cardiomyopathy	0.000477	0.00146	CbGpPWpGaD
Carfilzomib—PSMB8—Cell Cycle—LMNA—dilated cardiomyopathy	0.000476	0.00146	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—SDHA—dilated cardiomyopathy	0.00047	0.00144	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—IL10—dilated cardiomyopathy	0.000434	0.00133	CbGpPWpGaD
Carfilzomib—PSMB10—Apoptosis—TNF—dilated cardiomyopathy	0.000432	0.00132	CbGpPWpGaD
Carfilzomib—PSMB9—Apoptosis—TNF—dilated cardiomyopathy	0.00043	0.00132	CbGpPWpGaD
Carfilzomib—PSMB10—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000427	0.00131	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling by Wnt—RAC1—dilated cardiomyopathy	0.000426	0.00131	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling by Wnt—RAC1—dilated cardiomyopathy	0.000426	0.00131	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling by Wnt—RAC1—dilated cardiomyopathy	0.000426	0.00131	CbGpPWpGaD
Carfilzomib—PSMB9—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000425	0.0013	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling by Wnt—RAC1—dilated cardiomyopathy	0.00042	0.00129	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000416	0.00127	CbGpPWpGaD
Carfilzomib—PSMB10—Gene Expression—NPPA—dilated cardiomyopathy	0.000414	0.00127	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000414	0.00127	CbGpPWpGaD
Carfilzomib—PSMB9—Gene Expression—NPPA—dilated cardiomyopathy	0.000412	0.00126	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—FASLG—dilated cardiomyopathy	0.000403	0.00123	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—FAS—dilated cardiomyopathy	0.000389	0.00119	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—NPPA—dilated cardiomyopathy	0.000385	0.00118	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—NPPA—dilated cardiomyopathy	0.000383	0.00117	CbGpPWpGaD
Carfilzomib—PSMB10—B Cell Activation—EGFR—dilated cardiomyopathy	0.000377	0.00116	CbGpPWpGaD
Carfilzomib—PSMB9—B Cell Activation—EGFR—dilated cardiomyopathy	0.000375	0.00115	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—PSEN2—dilated cardiomyopathy	0.000373	0.00114	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—PSEN2—dilated cardiomyopathy	0.000371	0.00114	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000355	0.00109	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000353	0.00108	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000334	0.00102	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000333	0.00102	CbGpPWpGaD
Carfilzomib—PSMB1—Apoptosis—TNF—dilated cardiomyopathy	0.000327	0.001	CbGpPWpGaD
Carfilzomib—PSMB5—Apoptosis—TNF—dilated cardiomyopathy	0.000327	0.001	CbGpPWpGaD
Carfilzomib—PSMB2—Apoptosis—TNF—dilated cardiomyopathy	0.000327	0.001	CbGpPWpGaD
Carfilzomib—PSMB2—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000324	0.000991	CbGpPWpGaD
Carfilzomib—PSMB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000324	0.000991	CbGpPWpGaD
Carfilzomib—PSMB5—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000324	0.000991	CbGpPWpGaD
Carfilzomib—PSMB8—Apoptosis—TNF—dilated cardiomyopathy	0.000323	0.000988	CbGpPWpGaD
Carfilzomib—PSMB8—Downstream signaling events of B Cell Receptor (BCR)—EGFR—dilated cardiomyopathy	0.000319	0.000977	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000315	0.000966	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000315	0.000966	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000315	0.000966	CbGpPWpGaD
Carfilzomib—PSMB5—Gene Expression—NPPA—dilated cardiomyopathy	0.000314	0.000961	CbGpPWpGaD
Carfilzomib—PSMB1—Gene Expression—NPPA—dilated cardiomyopathy	0.000314	0.000961	CbGpPWpGaD
Carfilzomib—PSMB2—Gene Expression—NPPA—dilated cardiomyopathy	0.000314	0.000961	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—ITGB1—dilated cardiomyopathy	0.000311	0.000952	CbGpPWpGaD
Carfilzomib—PSMB8—Gene Expression—NPPA—dilated cardiomyopathy	0.00031	0.000948	CbGpPWpGaD
Carfilzomib—PSMB8—Cytokine Signaling in Immune system—RAF1—dilated cardiomyopathy	0.000308	0.000942	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—NPPA—dilated cardiomyopathy	0.000291	0.000893	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—NPPA—dilated cardiomyopathy	0.000291	0.000893	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—NPPA—dilated cardiomyopathy	0.000291	0.000893	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—NPPA—dilated cardiomyopathy	0.000287	0.00088	CbGpPWpGaD
Carfilzomib—PSMB5—B Cell Activation—EGFR—dilated cardiomyopathy	0.000286	0.000876	CbGpPWpGaD
Carfilzomib—PSMB1—B Cell Activation—EGFR—dilated cardiomyopathy	0.000286	0.000876	CbGpPWpGaD
Carfilzomib—PSMB2—B Cell Activation—EGFR—dilated cardiomyopathy	0.000286	0.000876	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—PSEN2—dilated cardiomyopathy	0.000282	0.000864	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—PSEN2—dilated cardiomyopathy	0.000282	0.000864	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—PSEN2—dilated cardiomyopathy	0.000282	0.000864	CbGpPWpGaD
Carfilzomib—PSMB8—B Cell Activation—EGFR—dilated cardiomyopathy	0.000282	0.000863	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—PSEN2—dilated cardiomyopathy	0.000278	0.000852	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000269	0.000824	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000269	0.000824	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000269	0.000824	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—CD36—dilated cardiomyopathy	0.000265	0.000812	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000261	0.000799	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.00026	0.000795	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000254	0.000776	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000254	0.000776	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.000254	0.000776	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—ITGB1—dilated cardiomyopathy	0.000252	0.000773	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—ITGB1—dilated cardiomyopathy	0.000251	0.000769	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—RYR2—dilated cardiomyopathy	0.000251	0.000769	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—RAC1—dilated cardiomyopathy	0.00025	0.000765	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—SLC22A5—dilated cardiomyopathy	0.000244	0.000748	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—PLN—dilated cardiomyopathy	0.000244	0.000748	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000232	0.000709	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000232	0.000709	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000231	0.000706	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000231	0.000706	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—ABCC9—dilated cardiomyopathy	0.000227	0.000695	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000222	0.000679	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000221	0.000676	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000215	0.000659	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—CD36—dilated cardiomyopathy	0.000215	0.000659	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000214	0.000656	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—CD36—dilated cardiomyopathy	0.000214	0.000656	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000209	0.000639	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000208	0.000636	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—RAC1—dilated cardiomyopathy	0.000203	0.000621	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—RAC1—dilated cardiomyopathy	0.000202	0.000618	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—dilated cardiomyopathy	0.000199	0.000609	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000198	0.000605	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000198	0.000605	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000198	0.000605	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000195	0.000597	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—dilated cardiomyopathy	0.000192	0.000587	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—ITGB1—dilated cardiomyopathy	0.000191	0.000586	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—ITGB1—dilated cardiomyopathy	0.000191	0.000586	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—ITGB1—dilated cardiomyopathy	0.000191	0.000586	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—ITGB1—dilated cardiomyopathy	0.000189	0.000577	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—RAC1—dilated cardiomyopathy	0.000188	0.000576	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—RAC1—dilated cardiomyopathy	0.000187	0.000574	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—RAC1—dilated cardiomyopathy	0.000186	0.000571	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000178	0.000545	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000177	0.000543	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000176	0.000538	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000176	0.000538	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000176	0.000538	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000176	0.000538	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000176	0.000538	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000176	0.000538	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000173	0.00053	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000173	0.00053	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—GPX1—dilated cardiomyopathy	0.000171	0.000523	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—GPX1—dilated cardiomyopathy	0.00017	0.000521	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000169	0.000517	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000168	0.000515	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000168	0.000515	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000168	0.000515	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000168	0.000515	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—CD36—dilated cardiomyopathy	0.000166	0.00051	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—RAF1—dilated cardiomyopathy	0.000166	0.000507	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—CD36—dilated cardiomyopathy	0.000166	0.000507	CbGpPWpGaD
Carfilzomib—ABCB1—Allograft Rejection—TNF—dilated cardiomyopathy	0.000165	0.000505	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—ANKRD1—dilated cardiomyopathy	0.000165	0.000505	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000163	0.0005	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000163	0.0005	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000163	0.0005	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—CD36—dilated cardiomyopathy	0.000163	0.0005	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—CD36—dilated cardiomyopathy	0.000163	0.0005	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—CD36—dilated cardiomyopathy	0.000163	0.0005	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000161	0.000493	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—CD36—dilated cardiomyopathy	0.000161	0.000493	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000158	0.000484	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000158	0.000484	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000158	0.000484	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000156	0.000477	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—TAZ—dilated cardiomyopathy	0.000155	0.000475	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—RAC1—dilated cardiomyopathy	0.000154	0.000471	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—RAC1—dilated cardiomyopathy	0.000154	0.000471	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—RAC1—dilated cardiomyopathy	0.000154	0.000471	CbGpPWpGaD
Carfilzomib—PSMB10—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000152	0.000466	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—RAC1—dilated cardiomyopathy	0.000152	0.000464	CbGpPWpGaD
Carfilzomib—PSMB9—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000151	0.000464	CbGpPWpGaD
Carfilzomib—PSMB10—Metabolism—AGT—dilated cardiomyopathy	0.00015	0.000459	CbGpPWpGaD
Carfilzomib—PSMB9—Metabolism—AGT—dilated cardiomyopathy	0.000149	0.000457	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000145	0.000445	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000144	0.000442	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—RAC1—dilated cardiomyopathy	0.000142	0.000435	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—RAC1—dilated cardiomyopathy	0.000142	0.000435	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—RAC1—dilated cardiomyopathy	0.000142	0.000435	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—SDHA—dilated cardiomyopathy	0.00014	0.00043	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—RAC1—dilated cardiomyopathy	0.00014	0.000429	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000135	0.000413	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000135	0.000413	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000135	0.000413	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—RAF1—dilated cardiomyopathy	0.000135	0.000412	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—RAF1—dilated cardiomyopathy	0.000134	0.00041	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000133	0.000407	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000131	0.000402	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000131	0.0004	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—GPX1—dilated cardiomyopathy	0.00013	0.000397	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—GPX1—dilated cardiomyopathy	0.00013	0.000397	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—GPX1—dilated cardiomyopathy	0.00013	0.000397	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000128	0.000392	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000128	0.000392	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000128	0.000392	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—GPX1—dilated cardiomyopathy	0.000128	0.000391	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000126	0.000387	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—CD36—dilated cardiomyopathy	0.000126	0.000386	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—CD36—dilated cardiomyopathy	0.000126	0.000386	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—CD36—dilated cardiomyopathy	0.000126	0.000386	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—AGT—dilated cardiomyopathy	0.000125	0.000384	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—AGT—dilated cardiomyopathy	0.000125	0.000382	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—RAF1—dilated cardiomyopathy	0.000125	0.000382	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—CD36—dilated cardiomyopathy	0.000124	0.000381	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—RAF1—dilated cardiomyopathy	0.000124	0.00038	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—RAF1—dilated cardiomyopathy	0.000124	0.000379	CbGpPWpGaD
Carfilzomib—PSMB1—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000115	0.000353	CbGpPWpGaD
Carfilzomib—PSMB5—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000115	0.000353	CbGpPWpGaD
Carfilzomib—PSMB2—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000115	0.000353	CbGpPWpGaD
Carfilzomib—PSMB8—Adaptive Immune System—EGFR—dilated cardiomyopathy	0.000114	0.000348	CbGpPWpGaD
Carfilzomib—PSMB1—Metabolism—AGT—dilated cardiomyopathy	0.000114	0.000348	CbGpPWpGaD
Carfilzomib—PSMB5—Metabolism—AGT—dilated cardiomyopathy	0.000114	0.000348	CbGpPWpGaD
Carfilzomib—PSMB2—Metabolism—AGT—dilated cardiomyopathy	0.000114	0.000348	CbGpPWpGaD
Carfilzomib—PSMB8—Metabolism—AGT—dilated cardiomyopathy	0.000112	0.000343	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00011	0.000337	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00011	0.000337	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.00011	0.000337	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000108	0.000332	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—RAF1—dilated cardiomyopathy	0.000102	0.000312	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—RAF1—dilated cardiomyopathy	0.000102	0.000312	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—RAF1—dilated cardiomyopathy	0.000102	0.000312	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—RAF1—dilated cardiomyopathy	0.000101	0.000308	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RAC1—dilated cardiomyopathy	9.94e-05	0.000304	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RAC1—dilated cardiomyopathy	9.94e-05	0.000304	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RAC1—dilated cardiomyopathy	9.94e-05	0.000304	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RAC1—dilated cardiomyopathy	9.8e-05	0.0003	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—AGT—dilated cardiomyopathy	9.5e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—AGT—dilated cardiomyopathy	9.5e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—AGT—dilated cardiomyopathy	9.5e-05	0.000291	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—RAF1—dilated cardiomyopathy	9.41e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—RAF1—dilated cardiomyopathy	9.41e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—RAF1—dilated cardiomyopathy	9.41e-05	0.000288	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—AGT—dilated cardiomyopathy	9.36e-05	0.000287	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—RAF1—dilated cardiomyopathy	9.28e-05	0.000284	CbGpPWpGaD
Carfilzomib—PSMB10—Immune System—EGFR—dilated cardiomyopathy	9.23e-05	0.000282	CbGpPWpGaD
Carfilzomib—PSMB9—Immune System—EGFR—dilated cardiomyopathy	9.18e-05	0.000281	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—RAF1—dilated cardiomyopathy	8.7e-05	0.000266	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—RAF1—dilated cardiomyopathy	8.66e-05	0.000265	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—dilated cardiomyopathy	8.55e-05	0.000262	CbGpPWpGaD
Carfilzomib—PSMB10—Disease—EGFR—dilated cardiomyopathy	8.52e-05	0.000261	CbGpPWpGaD
Carfilzomib—PSMB9—Disease—EGFR—dilated cardiomyopathy	8.48e-05	0.00026	CbGpPWpGaD
Carfilzomib—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—dilated cardiomyopathy	8.14e-05	0.000249	CbGpPWpGaD
Carfilzomib—PSMB5—Immune System—EGFR—dilated cardiomyopathy	6.99e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB2—Immune System—EGFR—dilated cardiomyopathy	6.99e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB1—Immune System—EGFR—dilated cardiomyopathy	6.99e-05	0.000214	CbGpPWpGaD
Carfilzomib—PSMB8—Immune System—EGFR—dilated cardiomyopathy	6.89e-05	0.000211	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—RAF1—dilated cardiomyopathy	6.59e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—RAF1—dilated cardiomyopathy	6.59e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—RAF1—dilated cardiomyopathy	6.59e-05	0.000202	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—RAF1—dilated cardiomyopathy	6.5e-05	0.000199	CbGpPWpGaD
Carfilzomib—PSMB1—Disease—EGFR—dilated cardiomyopathy	6.46e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB5—Disease—EGFR—dilated cardiomyopathy	6.46e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB2—Disease—EGFR—dilated cardiomyopathy	6.46e-05	0.000198	CbGpPWpGaD
Carfilzomib—PSMB8—Disease—EGFR—dilated cardiomyopathy	6.36e-05	0.000195	CbGpPWpGaD
Carfilzomib—PSMB10—Signaling Pathways—EGFR—dilated cardiomyopathy	5.96e-05	0.000183	CbGpPWpGaD
Carfilzomib—PSMB9—Signaling Pathways—EGFR—dilated cardiomyopathy	5.94e-05	0.000182	CbGpPWpGaD
Carfilzomib—ABCB1—Transmembrane transport of small molecules—RAF1—dilated cardiomyopathy	4.95e-05	0.000152	CbGpPWpGaD
Carfilzomib—PSMB5—Signaling Pathways—EGFR—dilated cardiomyopathy	4.52e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB1—Signaling Pathways—EGFR—dilated cardiomyopathy	4.52e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB2—Signaling Pathways—EGFR—dilated cardiomyopathy	4.52e-05	0.000138	CbGpPWpGaD
Carfilzomib—PSMB8—Signaling Pathways—EGFR—dilated cardiomyopathy	4.46e-05	0.000136	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—GPX1—dilated cardiomyopathy	3.81e-05	0.000117	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—CD36—dilated cardiomyopathy	3.71e-05	0.000114	CbGpPWpGaD
Carfilzomib—ABCB1—Metabolism—AGT—dilated cardiomyopathy	3.34e-05	0.000102	CbGpPWpGaD
